Pharma
CPhI and Informa Pharma Intelligence Concluded the 3rd Biopharma Conclave
Scientific R&D Underway for Therapeutic Antibodies Against COVID-19 by DBT/ Anti-COVID Consortium
Reinventing the Indian pharma business is no longer a choice but an imperative: EY report
Pfizer to Diversify Into Hospital Business, Would Also Split into Three Business Segments